MeridianLink, Inc. — Director's Dealing 2023

Jan 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MeridianLink, Inc. (MLNK)
CIK: 0001834494
Period of Report: 2023-01-03

Reporting Person: Maloof Chris (President, Go To Market)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-03	Common Stock, par value $0.001	M	6390	$6.0606	Acquired	275891	Direct
2023-01-03	Common Stock, par value $0.001	S	10892	$14.0156	Disposed	264999	Direct
2023-01-04	Common Stock, par value $0.001	M	25285	$6.0606	Acquired	290284	Direct
2023-01-04	Common Stock, par value $0.001	S	30891	$14.0981	Disposed	259393	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-01-03	Stock Option (option to buy)	$6.0606	M	6390	Disposed	2029-10-15	Common Stock, par value $0.001 (6390.0)	Direct
2023-01-04	Stock Option (option to buy)	$6.0606	M	25285	Disposed	2029-10-15	Common Stock, par value $0.001 (25285.0)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 28, 2022.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.10, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.33, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: With respect to (i) 75,000 of the shares underlying the option, 75% of such shares vested upon the Issuer's achievement of a predetermined EBITDA metric on each of December 31, 2019, 2020, and 2021, and the remaining 25% of such shares are scheduled to vest based upon the Issuer's level of achievement of a predetermined EBITDA metric for 2022; and (ii) 60,000 of the shares underlying the option, 25% of such shares vested on October 14, 2020, and the remaining 75% of such shares vest in 36 equal monthly instalments thereafter, in each case subject to the reporting person's continued service through the applicable vesting date.